These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 649393)
1. Evaluation of medicines returned in Glasgow DUMP campaign. Sixsmith DG; Smail GA Health Bull (Edinb); 1978 Mar; 36(2):88-90. PubMed ID: 649393 [No Abstract] [Full Text] [Related]
2. [Evaluation of public awareness campaigns on counterfeit medicines in Cotonou, Benin]. Abdoulaye I; Chastanier H; Azondekon A; Dansou A; Bruneton C Med Trop (Mars); 2006 Dec; 66(6):615-8. PubMed ID: 17286035 [TBL] [Abstract][Full Text] [Related]
3. The role of the pharmacopoeia in the control of pharmaceutical preparations. Grainger HS Ann Ist Super Sanita; 1975; 11(3-4):305-13. PubMed ID: 1234732 [TBL] [Abstract][Full Text] [Related]
4. Returned medicines: waste or a wasted opportunity? Mackridge AJ; Marriott JF J Public Health (Oxf); 2007 Sep; 29(3):258-62. PubMed ID: 17579236 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a sugar-free medicines campaign in north east England: analysis of findings from questionnaires. Evans DJ; Howe D; Maguire A; Rugg-Gunn AJ Community Dent Health; 1999 Sep; 16(3):131-7. PubMed ID: 10641070 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a sugar-free medicines campaign in north east England: quantitative analysis of medicines use. Maguire A; Evans DJ; Rugg-Gunn AJ; Butler TJ Community Dent Health; 1999 Sep; 16(3):138-44. PubMed ID: 10641071 [TBL] [Abstract][Full Text] [Related]
7. Convergent evolution of medicines. Kong DX; Li XJ; Zhang HY ChemMedChem; 2008 Aug; 3(8):1169-71. PubMed ID: 18491331 [No Abstract] [Full Text] [Related]
11. Evaluating Australia's National Medicines Policy using geographical mapping. Roughead EE; Monteith GR; Harvey KJ; Tett SE Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845 [TBL] [Abstract][Full Text] [Related]
12. Drug lag '80: the missing medicines. Rhein RW Med World News; 1980 Sep; 21(18):31-48. PubMed ID: 10317008 [No Abstract] [Full Text] [Related]
13. Vaccines and medicines for the world's poorest. Quality of vaccines and medicines must be monitored. Arya SC BMJ; 2000 Sep; 321(7264):834. PubMed ID: 11009543 [No Abstract] [Full Text] [Related]
14. The implications of developments in pharmaceutical analysis and new medicines on pharmaceutical education. Brain KR J Pharm Pharmacol; 1993 Apr; 45 Suppl 1():381-3. PubMed ID: 8098747 [No Abstract] [Full Text] [Related]
16. The impact of new medicines development on pharmaceutical analysis. Wiblin CN; Hambleton P; Melling J; Scawen M J Pharm Pharmacol; 1993 Apr; 45 Suppl 1():374-80. PubMed ID: 8098746 [No Abstract] [Full Text] [Related]
17. Prescribed and nonprescribed medicines. Type and use of medicines. Alderman AJ Vital Health Stat 10; 1967 Oct; 10(39):1-41. PubMed ID: 5299134 [No Abstract] [Full Text] [Related]
18. [Quality of medicines in least developed countries]. Videau JY Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015 [TBL] [Abstract][Full Text] [Related]
19. The rationale, organisation and evaluation of a campaign to increase the use of sugar-free paediatric medicines. Bentley E; Mackie I; Fuller SS Community Dent Health; 1997 Mar; 14(1):36-40. PubMed ID: 9114548 [TBL] [Abstract][Full Text] [Related]
20. The Innovative Medicines Initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients. Hunter AJ Drug Discov Today; 2008 May; 13(9-10):371-3. PubMed ID: 18468553 [No Abstract] [Full Text] [Related] [Next] [New Search]